Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02206971 · ClinicalTrials.gov registry record · NA
Biomarker Feedback for Smoking Cessation
A NA study, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 109
- Enrollment target
NCT02206971 is a NA study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 109 participants.
The verdict
NCT02206971, a NA study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the impact of providing light smokers with feedback about their health, including exposure to tobacco-related chemicals.
Interventions
- OTHER urine analyses feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02206971
The ClinicalTrials.gov registry entry for NCT02206971 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which urine analyses feedback is the first listed.
NCT02206971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02206971 about?
NCT02206971 is a clinical study titled "Biomarker Feedback for Smoking Cessation". The purpose of this study is to examine the impact of providing light smokers with feedback about their health, including exposure to tobacco-related chemicals.
What is the current status of trial NCT02206971?
This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2012-05. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02206971?
The interventions under investigation include: urine analyses feedback (OTHER).
Who is sponsoring clinical trial NCT02206971?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.